| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Von Hippel-Lindau Tumor Suppressor Protein | 78 | 2024 | 304 | 10.230 |
Why?
|
| von Hippel-Lindau Disease | 39 | 2024 | 151 | 6.860 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 24 | 2024 | 1135 | 4.770 |
Why?
|
| Carcinoma, Renal Cell | 49 | 2024 | 3153 | 4.680 |
Why?
|
| Kidney Neoplasms | 50 | 2024 | 4221 | 4.420 |
Why?
|
| Ubiquitin-Protein Ligases | 50 | 2018 | 1889 | 4.270 |
Why?
|
| Ligases | 37 | 2022 | 332 | 4.060 |
Why?
|
| Genes, Tumor Suppressor | 44 | 2018 | 1055 | 3.960 |
Why?
|
| Tumor Suppressor Proteins | 66 | 2016 | 2800 | 3.910 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 37 | 2024 | 611 | 3.580 |
Why?
|
| Procollagen-Proline Dioxygenase | 16 | 2013 | 81 | 3.090 |
Why?
|
| Retinoblastoma Protein | 31 | 2018 | 670 | 2.770 |
Why?
|
| Oxygen | 25 | 2022 | 4190 | 2.650 |
Why?
|
| Hypoxia-Inducible Factor 1 | 22 | 2019 | 193 | 2.360 |
Why?
|
| Nuclear Proteins | 39 | 2019 | 5786 | 2.250 |
Why?
|
| DNA-Binding Proteins | 61 | 2018 | 9574 | 2.190 |
Why?
|
| Transcription Factors | 78 | 2023 | 12092 | 2.140 |
Why?
|
| Dioxygenases | 9 | 2020 | 332 | 1.760 |
Why?
|
| Cell Cycle Proteins | 40 | 2015 | 3443 | 1.710 |
Why?
|
| Ketoglutaric Acids | 4 | 2020 | 75 | 1.680 |
Why?
|
| Indans | 4 | 2022 | 92 | 1.610 |
Why?
|
| Proteins | 32 | 2022 | 6026 | 1.480 |
Why?
|
| Glutarates | 6 | 2018 | 243 | 1.460 |
Why?
|
| Sulfones | 4 | 2022 | 446 | 1.370 |
Why?
|
| Neoplasms | 44 | 2020 | 21990 | 1.360 |
Why?
|
| Gene Expression Regulation, Neoplastic | 31 | 2022 | 8505 | 1.270 |
Why?
|
| Tumor Suppressor Protein p53 | 20 | 2022 | 2913 | 1.240 |
Why?
|
| Proline | 10 | 2023 | 456 | 1.120 |
Why?
|
| Carrier Proteins | 29 | 2001 | 4937 | 1.070 |
Why?
|
| Small Cell Lung Carcinoma | 3 | 2019 | 420 | 1.050 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2019 | 2824 | 1.020 |
Why?
|
| Thalidomide | 4 | 2022 | 884 | 1.000 |
Why?
|
| Cullin Proteins | 8 | 2003 | 180 | 1.000 |
Why?
|
| Animals | 144 | 2024 | 167777 | 0.990 |
Why?
|
| Isocitrate Dehydrogenase | 9 | 2023 | 928 | 0.970 |
Why?
|
| Kynurenic Acid | 2 | 2022 | 44 | 0.960 |
Why?
|
| Mitochondria, Heart | 2 | 2024 | 229 | 0.950 |
Why?
|
| Trans-Activators | 15 | 2019 | 2859 | 0.950 |
Why?
|
| Cell Cycle | 26 | 2008 | 2930 | 0.940 |
Why?
|
| Pheochromocytoma | 11 | 2019 | 328 | 0.930 |
Why?
|
| Paraganglioma | 5 | 2024 | 142 | 0.930 |
Why?
|
| Hexosyltransferases | 1 | 2024 | 58 | 0.920 |
Why?
|
| Indigofera | 1 | 2023 | 2 | 0.920 |
Why?
|
| Mice | 88 | 2024 | 81107 | 0.890 |
Why?
|
| Cell Hypoxia | 16 | 2020 | 656 | 0.890 |
Why?
|
| RNA, Small Interfering | 15 | 2022 | 3432 | 0.850 |
Why?
|
| Ubiquitins | 11 | 2022 | 366 | 0.840 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 3 | 2019 | 27 | 0.820 |
Why?
|
| Signal Transduction | 24 | 2024 | 23342 | 0.810 |
Why?
|
| Antineoplastic Agents | 18 | 2020 | 13603 | 0.800 |
Why?
|
| Vascular Endothelial Growth Factor A | 11 | 2022 | 3480 | 0.800 |
Why?
|
| Adrenal Gland Neoplasms | 8 | 2021 | 732 | 0.770 |
Why?
|
| Glioma | 7 | 2023 | 3417 | 0.770 |
Why?
|
| Transcription, Genetic | 28 | 2019 | 7590 | 0.770 |
Why?
|
| Repressor Proteins | 11 | 2015 | 2976 | 0.770 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 5 | 2015 | 175 | 0.760 |
Why?
|
| CDC2-CDC28 Kinases | 5 | 2004 | 110 | 0.760 |
Why?
|
| Mutation | 54 | 2023 | 29928 | 0.750 |
Why?
|
| Genes, p53 | 8 | 2003 | 712 | 0.750 |
Why?
|
| Erythropoietin | 3 | 2012 | 719 | 0.740 |
Why?
|
| Molecular Targeted Therapy | 5 | 2020 | 2796 | 0.720 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2019 | 171 | 0.720 |
Why?
|
| F-Box Proteins | 3 | 2015 | 202 | 0.720 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 577 | 0.720 |
Why?
|
| Ikaros Transcription Factor | 3 | 2021 | 231 | 0.710 |
Why?
|
| Cell Line, Tumor | 29 | 2024 | 16891 | 0.700 |
Why?
|
| Hydroxylation | 15 | 2023 | 137 | 0.700 |
Why?
|
| Histone Demethylases | 3 | 2019 | 319 | 0.690 |
Why?
|
| NF-kappa B | 3 | 2024 | 2472 | 0.690 |
Why?
|
| Hemangioblastoma | 6 | 2010 | 63 | 0.660 |
Why?
|
| E2F Transcription Factors | 26 | 2003 | 269 | 0.650 |
Why?
|
| Neuroendocrine Cells | 1 | 2019 | 62 | 0.650 |
Why?
|
| Quinazolines | 3 | 2021 | 1371 | 0.640 |
Why?
|
| Humans | 216 | 2024 | 757650 | 0.620 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 24 | 2000 | 138 | 0.620 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2018 | 101 | 0.610 |
Why?
|
| Molecular Sequence Data | 41 | 2015 | 17617 | 0.610 |
Why?
|
| RNA Interference | 8 | 2020 | 2836 | 0.610 |
Why?
|
| Transaminases | 1 | 2018 | 196 | 0.590 |
Why?
|
| Tumor Cells, Cultured | 31 | 2018 | 6128 | 0.590 |
Why?
|
| Genes, Retinoblastoma | 5 | 2018 | 125 | 0.590 |
Why?
|
| Peptides | 4 | 2019 | 4340 | 0.590 |
Why?
|
| Mice, Nude | 16 | 2019 | 3602 | 0.590 |
Why?
|
| Transcription Factor DP1 | 23 | 2000 | 136 | 0.590 |
Why?
|
| Oncogene Proteins, Viral | 8 | 2000 | 342 | 0.580 |
Why?
|
| Citric Acid Cycle | 5 | 2020 | 230 | 0.580 |
Why?
|
| Transcriptional Activation | 13 | 2010 | 1753 | 0.580 |
Why?
|
| Ubiquitination | 4 | 2020 | 1008 | 0.570 |
Why?
|
| Humanities | 1 | 2017 | 55 | 0.570 |
Why?
|
| Histone Code | 1 | 2018 | 155 | 0.570 |
Why?
|
| Cyclin-Dependent Kinases | 7 | 2019 | 655 | 0.570 |
Why?
|
| Polycythemia | 4 | 2021 | 125 | 0.560 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2019 | 345 | 0.560 |
Why?
|
| Fumarate Hydratase | 2 | 2014 | 52 | 0.560 |
Why?
|
| Mammals | 3 | 2012 | 1132 | 0.560 |
Why?
|
| Apoptosis | 22 | 2022 | 9469 | 0.560 |
Why?
|
| Oncogene Proteins | 1 | 2021 | 719 | 0.550 |
Why?
|
| Immediate-Early Proteins | 4 | 2008 | 449 | 0.550 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 3608 | 0.540 |
Why?
|
| Research Report | 1 | 2019 | 367 | 0.540 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 2204 | 0.540 |
Why?
|
| Famous Persons | 1 | 2017 | 109 | 0.530 |
Why?
|
| Base Sequence | 30 | 2017 | 12437 | 0.530 |
Why?
|
| Autophagy | 1 | 2024 | 1322 | 0.530 |
Why?
|
| Phosphoproteins | 8 | 2002 | 2433 | 0.530 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 555 | 0.510 |
Why?
|
| Glutamic Acid | 2 | 2018 | 1167 | 0.510 |
Why?
|
| G1 Phase | 10 | 2020 | 403 | 0.510 |
Why?
|
| Amino Acid Sequence | 28 | 2017 | 13447 | 0.510 |
Why?
|
| Ischemic Preconditioning | 1 | 2016 | 89 | 0.510 |
Why?
|
| Cell Physiological Phenomena | 1 | 2016 | 150 | 0.500 |
Why?
|
| Myocardial Ischemia | 2 | 2024 | 2108 | 0.500 |
Why?
|
| Proto-Oncogene Proteins c-abl | 2 | 2014 | 140 | 0.500 |
Why?
|
| S-Phase Kinase-Associated Proteins | 6 | 2020 | 90 | 0.500 |
Why?
|
| Cell Line | 29 | 2020 | 15594 | 0.500 |
Why?
|
| Luciferases | 5 | 2005 | 714 | 0.490 |
Why?
|
| Cardiomyopathies | 3 | 2024 | 1945 | 0.490 |
Why?
|
| Cyclins | 6 | 1999 | 593 | 0.480 |
Why?
|
| Receptors, Notch | 1 | 2019 | 743 | 0.480 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2019 | 786 | 0.480 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 1245 | 0.480 |
Why?
|
| Paracrine Communication | 1 | 2016 | 276 | 0.480 |
Why?
|
| Science | 1 | 2017 | 239 | 0.480 |
Why?
|
| Congresses as Topic | 1 | 2019 | 799 | 0.480 |
Why?
|
| Protein Binding | 33 | 2015 | 9312 | 0.480 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2014 | 63 | 0.470 |
Why?
|
| Disease Models, Animal | 10 | 2024 | 18123 | 0.460 |
Why?
|
| Cell Proliferation | 10 | 2018 | 10416 | 0.450 |
Why?
|
| Gene Expression Regulation | 21 | 2017 | 11893 | 0.450 |
Why?
|
| Membrane Proteins | 4 | 2024 | 7841 | 0.450 |
Why?
|
| Teratogens | 1 | 2013 | 117 | 0.430 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 3 | 2019 | 169 | 0.430 |
Why?
|
| Cyclin-Dependent Kinase 2 | 6 | 2005 | 184 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 385 | 0.410 |
Why?
|
| Gene Dosage | 3 | 2013 | 1218 | 0.400 |
Why?
|
| Cell Differentiation | 9 | 2019 | 11470 | 0.400 |
Why?
|
| Feedback, Physiological | 2 | 2017 | 475 | 0.400 |
Why?
|
| Metabolism | 2 | 2013 | 193 | 0.400 |
Why?
|
| Enzyme Inhibitors | 7 | 2022 | 3709 | 0.400 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1335 | 0.390 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2021 | 2895 | 0.390 |
Why?
|
| Binding Sites | 23 | 2014 | 6036 | 0.390 |
Why?
|
| src-Family Kinases | 1 | 2014 | 535 | 0.390 |
Why?
|
| Cysteine | 1 | 2016 | 893 | 0.380 |
Why?
|
| E2F1 Transcription Factor | 17 | 2003 | 178 | 0.380 |
Why?
|
| Recombinant Fusion Proteins | 20 | 2018 | 3734 | 0.380 |
Why?
|
| Climate Change | 1 | 2017 | 486 | 0.370 |
Why?
|
| Politics | 1 | 2017 | 815 | 0.370 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 622 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2011 | 286 | 0.360 |
Why?
|
| Chromatin | 3 | 2019 | 2938 | 0.360 |
Why?
|
| Histones | 6 | 2019 | 2577 | 0.360 |
Why?
|
| Mutagenesis, Site-Directed | 9 | 2020 | 1693 | 0.360 |
Why?
|
| Myocardial Stunning | 1 | 2010 | 66 | 0.360 |
Why?
|
| Leukemia | 2 | 2022 | 1521 | 0.350 |
Why?
|
| Liver | 10 | 2016 | 7503 | 0.350 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2010 | 68 | 0.350 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2011 | 147 | 0.340 |
Why?
|
| Publishing | 1 | 2017 | 832 | 0.340 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2019 | 3575 | 0.340 |
Why?
|
| HEK293 Cells | 5 | 2024 | 4258 | 0.340 |
Why?
|
| Protein Kinases | 5 | 2004 | 1610 | 0.340 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 1313 | 0.330 |
Why?
|
| Homeostasis | 3 | 2018 | 3302 | 0.330 |
Why?
|
| Transfection | 14 | 2009 | 5779 | 0.330 |
Why?
|
| CARD Signaling Adaptor Proteins | 2 | 2007 | 159 | 0.330 |
Why?
|
| HeLa Cells | 9 | 2015 | 3095 | 0.320 |
Why?
|
| Methylation | 5 | 2019 | 1080 | 0.320 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2004 | 1972 | 0.320 |
Why?
|
| Myocytes, Cardiac | 2 | 2024 | 1655 | 0.320 |
Why?
|
| Genes | 2 | 2012 | 1844 | 0.310 |
Why?
|
| Research | 1 | 2017 | 1975 | 0.310 |
Why?
|
| Integrases | 2 | 2018 | 516 | 0.310 |
Why?
|
| Energy Metabolism | 1 | 2019 | 2868 | 0.310 |
Why?
|
| Gene Knockdown Techniques | 2 | 2012 | 1609 | 0.310 |
Why?
|
| Cell Division | 14 | 2008 | 4459 | 0.310 |
Why?
|
| Health Care Reform | 1 | 2017 | 1245 | 0.310 |
Why?
|
| S Phase | 9 | 2020 | 422 | 0.310 |
Why?
|
| Down-Regulation | 8 | 2009 | 2903 | 0.300 |
Why?
|
| Luminescent Measurements | 3 | 2004 | 341 | 0.300 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2017 | 1181 | 0.300 |
Why?
|
| Disease | 1 | 2013 | 671 | 0.290 |
Why?
|
| Enzyme Activation | 5 | 2018 | 3593 | 0.290 |
Why?
|
| Reactive Oxygen Species | 3 | 2020 | 2129 | 0.290 |
Why?
|
| Models, Animal | 3 | 2016 | 2112 | 0.290 |
Why?
|
| Chromosomes, Mammalian | 1 | 2008 | 146 | 0.290 |
Why?
|
| Casein Kinase II | 1 | 2007 | 122 | 0.280 |
Why?
|
| Point Mutation | 4 | 2011 | 1594 | 0.280 |
Why?
|
| Retinol-Binding Proteins | 1 | 2007 | 67 | 0.280 |
Why?
|
| Peptide Synthases | 3 | 2002 | 80 | 0.280 |
Why?
|
| Models, Biological | 13 | 2016 | 9460 | 0.280 |
Why?
|
| Endothelial Growth Factors | 4 | 2003 | 672 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-jun | 3 | 2011 | 285 | 0.270 |
Why?
|
| Glycolysis | 3 | 2020 | 826 | 0.270 |
Why?
|
| Germ-Line Mutation | 6 | 2010 | 1840 | 0.270 |
Why?
|
| Antigens, Polyomavirus Transforming | 3 | 1992 | 257 | 0.270 |
Why?
|
| Plasmids | 8 | 2005 | 2275 | 0.260 |
Why?
|
| Drug Design | 3 | 2007 | 1049 | 0.260 |
Why?
|
| Lymphokines | 4 | 2003 | 926 | 0.260 |
Why?
|
| Piperidines | 1 | 2014 | 1639 | 0.260 |
Why?
|
| Research Design | 2 | 2017 | 6151 | 0.260 |
Why?
|
| Mice, Mutant Strains | 5 | 2011 | 1751 | 0.260 |
Why?
|
| Oncogene Protein p65(gag-jun) | 1 | 2005 | 7 | 0.260 |
Why?
|
| Clusterin | 1 | 2006 | 71 | 0.260 |
Why?
|
| Genes, Lethal | 2 | 2005 | 225 | 0.260 |
Why?
|
| Drugs, Investigational | 1 | 2007 | 212 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 22008 | 0.250 |
Why?
|
| Acetyl-CoA Carboxylase | 2 | 2016 | 72 | 0.250 |
Why?
|
| Oncogenes | 4 | 2018 | 1222 | 0.250 |
Why?
|
| Neovascularization, Pathologic | 8 | 2003 | 2638 | 0.240 |
Why?
|
| Cells, Cultured | 14 | 2014 | 18941 | 0.240 |
Why?
|
| Multigene Family | 2 | 1999 | 1076 | 0.240 |
Why?
|
| Hydroxyproline | 2 | 2002 | 110 | 0.240 |
Why?
|
| Succinate Dehydrogenase | 4 | 2010 | 145 | 0.240 |
Why?
|
| Indoles | 2 | 2023 | 1825 | 0.240 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3102 | 0.240 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 2326 | 0.240 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 818 | 0.230 |
Why?
|
| Mice, Transgenic | 6 | 2012 | 9519 | 0.230 |
Why?
|
| Fibroblasts | 7 | 2018 | 4087 | 0.230 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2004 | 59 | 0.230 |
Why?
|
| Calcium Channels | 1 | 2008 | 618 | 0.230 |
Why?
|
| DNA Primers | 7 | 2005 | 2816 | 0.230 |
Why?
|
| Catalytic Domain | 2 | 2024 | 705 | 0.230 |
Why?
|
| Phosphorylation | 11 | 2016 | 8298 | 0.220 |
Why?
|
| Peroxisomes | 1 | 2024 | 68 | 0.220 |
Why?
|
| Erythropoiesis | 4 | 2014 | 682 | 0.220 |
Why?
|
| Mice, Knockout | 10 | 2024 | 14354 | 0.220 |
Why?
|
| Hematopoiesis | 1 | 2013 | 2047 | 0.220 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 977 | 0.220 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 408 | 0.220 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 855 | 0.220 |
Why?
|
| Piperazines | 3 | 2019 | 2511 | 0.220 |
Why?
|
| Macromolecular Substances | 9 | 2002 | 1433 | 0.210 |
Why?
|
| Neoplasm Transplantation | 4 | 2016 | 2013 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factors | 5 | 2012 | 747 | 0.210 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 3754 | 0.210 |
Why?
|
| Receptors, Growth Factor | 2 | 2008 | 326 | 0.210 |
Why?
|
| Indazoles | 1 | 2024 | 302 | 0.210 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 1526 | 0.210 |
Why?
|
| Cyclin A | 2 | 2001 | 60 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 10 | 2004 | 5779 | 0.200 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 256 | 0.200 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2002 | 45 | 0.200 |
Why?
|
| DNA, Complementary | 4 | 2005 | 1991 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 9 | 2007 | 3795 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 10 | 2015 | 4491 | 0.200 |
Why?
|
| Hamartoma | 1 | 2004 | 235 | 0.200 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2010 | 916 | 0.200 |
Why?
|
| Phenotype | 14 | 2014 | 16533 | 0.200 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 20039 | 0.200 |
Why?
|
| Adenovirus E1A Proteins | 2 | 2000 | 73 | 0.200 |
Why?
|
| Alleles | 7 | 2018 | 6894 | 0.190 |
Why?
|
| Adenovirus E4 Proteins | 2 | 2001 | 7 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 5254 | 0.190 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 1986 | 0.190 |
Why?
|
| PC12 Cells | 3 | 2019 | 317 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2010 | 17767 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2019 | 5639 | 0.190 |
Why?
|
| Indenes | 1 | 2021 | 58 | 0.190 |
Why?
|
| Gene Expression Profiling | 10 | 2019 | 9404 | 0.190 |
Why?
|
| Cell Survival | 5 | 2019 | 5782 | 0.180 |
Why?
|
| Glycosylation | 1 | 2024 | 1095 | 0.180 |
Why?
|
| Biology | 1 | 2023 | 289 | 0.180 |
Why?
|
| Cyclin E | 1 | 2001 | 156 | 0.180 |
Why?
|
| Immunoblotting | 5 | 2009 | 1647 | 0.180 |
Why?
|
| Asparagine | 3 | 2008 | 119 | 0.180 |
Why?
|
| Enzyme Stability | 3 | 2011 | 219 | 0.180 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2018 | 1114 | 0.180 |
Why?
|
| Fetal Development | 1 | 2006 | 766 | 0.180 |
Why?
|
| Cryoelectron Microscopy | 1 | 2024 | 642 | 0.170 |
Why?
|
| Cell Respiration | 1 | 2020 | 202 | 0.170 |
Why?
|
| E2F4 Transcription Factor | 4 | 2012 | 32 | 0.170 |
Why?
|
| Retinol-Binding Proteins, Cellular | 2 | 2011 | 12 | 0.170 |
Why?
|
| Benzylamines | 1 | 2021 | 247 | 0.170 |
Why?
|
| Drug Delivery Systems | 3 | 2010 | 2211 | 0.170 |
Why?
|
| Fibronectins | 6 | 2004 | 722 | 0.170 |
Why?
|
| Rabbits | 2 | 2022 | 4771 | 0.160 |
Why?
|
| Adaptation, Physiological | 2 | 2017 | 1294 | 0.160 |
Why?
|
| RNA, Untranslated | 2 | 2017 | 459 | 0.160 |
Why?
|
| Lung Neoplasms | 3 | 2019 | 13267 | 0.160 |
Why?
|
| Retroviridae | 4 | 2008 | 850 | 0.160 |
Why?
|
| Conserved Sequence | 2 | 2007 | 1164 | 0.160 |
Why?
|
| Aminopyridines | 2 | 2019 | 564 | 0.160 |
Why?
|
| Pyrroles | 2 | 2019 | 1127 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 4 | 2010 | 367 | 0.160 |
Why?
|
| Retinoblastoma | 3 | 1998 | 317 | 0.160 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2001 | 220 | 0.160 |
Why?
|
| DNA | 9 | 2001 | 7199 | 0.150 |
Why?
|
| Neuroendocrine Tumors | 1 | 2024 | 641 | 0.150 |
Why?
|
| Optic Disk | 1 | 2002 | 421 | 0.150 |
Why?
|
| Models, Genetic | 4 | 2005 | 3441 | 0.150 |
Why?
|
| RNA, Messenger | 9 | 2007 | 12761 | 0.150 |
Why?
|
| Adenocarcinoma, Clear Cell | 3 | 2004 | 217 | 0.150 |
Why?
|
| Gene Deletion | 7 | 2011 | 2666 | 0.150 |
Why?
|
| Ubiquitin | 6 | 2006 | 837 | 0.150 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 293 | 0.140 |
Why?
|
| Pregnancy Proteins | 1 | 2018 | 222 | 0.140 |
Why?
|
| Chromosome Segregation | 1 | 2018 | 233 | 0.140 |
Why?
|
| DNA Damage | 4 | 2020 | 2439 | 0.140 |
Why?
|
| New York City | 1 | 2019 | 726 | 0.140 |
Why?
|
| Alternative Splicing | 2 | 2018 | 1091 | 0.140 |
Why?
|
| Extracellular Matrix | 5 | 2004 | 1723 | 0.140 |
Why?
|
| Chromosome Mapping | 5 | 2010 | 4624 | 0.140 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 3705 | 0.140 |
Why?
|
| Mass Spectrometry | 3 | 2015 | 2189 | 0.140 |
Why?
|
| Heart Septal Defects | 1 | 2018 | 191 | 0.140 |
Why?
|
| Cyclin D1 | 3 | 2014 | 451 | 0.140 |
Why?
|
| Recombinant Proteins | 7 | 2017 | 6525 | 0.140 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2005 | 1622 | 0.140 |
Why?
|
| Retinal Neoplasms | 2 | 1999 | 146 | 0.140 |
Why?
|
| Neuroblastoma | 3 | 2015 | 1248 | 0.140 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2016 | 37 | 0.130 |
Why?
|
| Glutathione | 1 | 2019 | 581 | 0.130 |
Why?
|
| Substrate Specificity | 4 | 2018 | 1791 | 0.130 |
Why?
|
| Growth Inhibitors | 3 | 1997 | 378 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 2443 | 0.130 |
Why?
|
| Viral Proteins | 1 | 2003 | 1803 | 0.130 |
Why?
|
| Tuberous Sclerosis | 1 | 2004 | 1030 | 0.130 |
Why?
|
| DNA Mutational Analysis | 6 | 2019 | 4107 | 0.130 |
Why?
|
| Parabiosis | 1 | 2016 | 64 | 0.130 |
Why?
|
| Zea mays | 1 | 1996 | 112 | 0.130 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2015 | 21 | 0.130 |
Why?
|
| Multiple Myeloma | 1 | 2013 | 5129 | 0.130 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2016 | 162 | 0.130 |
Why?
|
| Cloning, Molecular | 7 | 2002 | 4169 | 0.130 |
Why?
|
| Polyubiquitin | 1 | 2015 | 68 | 0.130 |
Why?
|
| 3T3 Cells | 6 | 2004 | 1084 | 0.130 |
Why?
|
| Genomic Instability | 1 | 2019 | 705 | 0.130 |
Why?
|
| Succinic Acid | 1 | 2015 | 84 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 1611 | 0.120 |
Why?
|
| Peptide Fragments | 2 | 1999 | 5098 | 0.120 |
Why?
|
| Species Specificity | 1 | 2019 | 2416 | 0.120 |
Why?
|
| Simian virus 40 | 2 | 1998 | 291 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 2223 | 0.120 |
Why?
|
| Fumarates | 1 | 2015 | 131 | 0.120 |
Why?
|
| Pyridines | 2 | 2019 | 2864 | 0.120 |
Why?
|
| Dimerization | 3 | 2007 | 888 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 4406 | 0.120 |
Why?
|
| Tumor Burden | 3 | 2019 | 1887 | 0.120 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2014 | 15 | 0.120 |
Why?
|
| Frameshift Mutation | 1 | 2017 | 388 | 0.120 |
Why?
|
| History, 19th Century | 1 | 2017 | 720 | 0.120 |
Why?
|
| Gene Silencing | 3 | 2008 | 1507 | 0.120 |
Why?
|
| Mitochondria | 3 | 2015 | 3584 | 0.120 |
Why?
|
| Pyrimidines | 2 | 2022 | 3005 | 0.120 |
Why?
|
| Transgenes | 1 | 2018 | 1007 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2010 | 315 | 0.120 |
Why?
|
| Mice, SCID | 3 | 2018 | 2625 | 0.120 |
Why?
|
| Quality Control | 1 | 2017 | 825 | 0.120 |
Why?
|
| Benzimidazoles | 1 | 2019 | 855 | 0.120 |
Why?
|
| Acclimatization | 1 | 2014 | 112 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2000 | 1851 | 0.110 |
Why?
|
| Acidosis, Lactic | 1 | 2015 | 145 | 0.110 |
Why?
|
| Gene Targeting | 2 | 2012 | 837 | 0.110 |
Why?
|
| Carcinoma | 3 | 2008 | 2330 | 0.110 |
Why?
|
| Rats | 12 | 2019 | 23681 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2004 | 203 | 0.110 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2013 | 23 | 0.110 |
Why?
|
| Mice, Inbred NOD | 2 | 2016 | 1824 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2007 | 2047 | 0.110 |
Why?
|
| Adenoviruses, Human | 2 | 1997 | 255 | 0.110 |
Why?
|
| Tamoxifen | 1 | 2018 | 964 | 0.110 |
Why?
|
| HCT116 Cells | 1 | 2014 | 402 | 0.110 |
Why?
|
| Brain Neoplasms | 4 | 2023 | 8981 | 0.110 |
Why?
|
| Adenocarcinoma | 4 | 2019 | 6325 | 0.110 |
Why?
|
| Glucose Transporter Type 1 | 4 | 2004 | 186 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 877 | 0.110 |
Why?
|
| Inflammation | 4 | 2024 | 10718 | 0.110 |
Why?
|
| Breast Neoplasms | 4 | 2016 | 20999 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2013 | 126 | 0.110 |
Why?
|
| Visual Acuity | 1 | 2002 | 2642 | 0.100 |
Why?
|
| Genotype | 7 | 2015 | 12951 | 0.100 |
Why?
|
| DNA Methylation | 3 | 2013 | 4374 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2010 | 2056 | 0.100 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2016 | 478 | 0.100 |
Why?
|
| Genes, cdc | 1 | 2012 | 115 | 0.100 |
Why?
|
| Kidney | 4 | 2009 | 7013 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 1018 | 0.100 |
Why?
|
| Retinoblastoma-Like Protein p130 | 2 | 2005 | 73 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 1984 | 507 | 0.100 |
Why?
|
| Awards and Prizes | 1 | 2016 | 359 | 0.100 |
Why?
|
| Monosaccharide Transport Proteins | 4 | 2004 | 436 | 0.100 |
Why?
|
| Mixed Function Oxygenases | 2 | 2015 | 265 | 0.100 |
Why?
|
| Cell Extracts | 2 | 2004 | 135 | 0.100 |
Why?
|
| Qb-SNARE Proteins | 1 | 2011 | 34 | 0.100 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 1147 | 0.100 |
Why?
|
| Adenovirus Early Proteins | 4 | 1992 | 57 | 0.100 |
Why?
|
| Anemia | 2 | 2012 | 1503 | 0.100 |
Why?
|
| Chaperonins | 2 | 2002 | 58 | 0.100 |
Why?
|
| Protein Isoforms | 3 | 2020 | 1694 | 0.100 |
Why?
|
| Female | 30 | 2022 | 389985 | 0.090 |
Why?
|
| Catalysis | 1 | 2013 | 772 | 0.090 |
Why?
|
| DNA Replication | 2 | 2008 | 1410 | 0.090 |
Why?
|
| Adrenal Glands | 2 | 2021 | 553 | 0.090 |
Why?
|
| Flow Cytometry | 2 | 2004 | 5864 | 0.090 |
Why?
|
| Echocardiography | 2 | 2018 | 4962 | 0.090 |
Why?
|
| Anilides | 1 | 2014 | 409 | 0.090 |
Why?
|
| Embryo, Mammalian | 4 | 2007 | 1674 | 0.090 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2014 | 454 | 0.090 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 152 | 0.090 |
Why?
|
| Cell Separation | 1 | 1997 | 1720 | 0.090 |
Why?
|
| Genes, Reporter | 3 | 2004 | 1527 | 0.090 |
Why?
|
| Survival Analysis | 3 | 2016 | 10075 | 0.090 |
Why?
|
| DNA Helicases | 1 | 1996 | 853 | 0.090 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 374 | 0.090 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2012 | 617 | 0.090 |
Why?
|
| Antioxidants | 1 | 2019 | 1665 | 0.090 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2010 | 32 | 0.090 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 749 | 0.090 |
Why?
|
| Casein Kinase I | 1 | 2010 | 46 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 1708 | 0.090 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2019 | 37 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2010 | 989 | 0.090 |
Why?
|
| Isoenzymes | 2 | 2008 | 1686 | 0.090 |
Why?
|
| Deferoxamine | 2 | 2001 | 153 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2016 | 3599 | 0.090 |
Why?
|
| Acetylation | 1 | 2013 | 1060 | 0.090 |
Why?
|
| Histone Deacetylases | 2 | 2008 | 719 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 283 | 0.090 |
Why?
|
| Protein Conformation | 5 | 2002 | 3967 | 0.090 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2012 | 354 | 0.090 |
Why?
|
| Flavoproteins | 1 | 2009 | 40 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 3524 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 597 | 0.080 |
Why?
|
| Electron Transport Complex II | 1 | 2009 | 53 | 0.080 |
Why?
|
| Spheroids, Cellular | 3 | 2007 | 329 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 4283 | 0.080 |
Why?
|
| Genomics | 4 | 2022 | 5788 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2003 | 5031 | 0.080 |
Why?
|
| Neoplasm Metastasis | 3 | 2016 | 4888 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2006 | 1135 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2017 | 1044 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 441 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 1422 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 2019 | 1648 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2006 | 319 | 0.080 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 677 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2412 | 0.080 |
Why?
|
| Hematocrit | 1 | 2010 | 625 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 9163 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 633 | 0.080 |
Why?
|
| Heart Function Tests | 1 | 2009 | 318 | 0.080 |
Why?
|
| Models, Molecular | 5 | 2016 | 5411 | 0.080 |
Why?
|
| Codon | 2 | 2000 | 601 | 0.080 |
Why?
|
| Male | 18 | 2024 | 358227 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2016 | 1804 | 0.080 |
Why?
|
| Myositis | 1 | 1991 | 269 | 0.080 |
Why?
|
| Multiprotein Complexes | 4 | 2012 | 1120 | 0.080 |
Why?
|
| Sequence Alignment | 3 | 2011 | 2176 | 0.080 |
Why?
|
| Oxidative Phosphorylation | 1 | 2010 | 495 | 0.080 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2008 | 89 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2003 | 2497 | 0.070 |
Why?
|
| Nerve Growth Factor | 2 | 2006 | 158 | 0.070 |
Why?
|
| Organ Specificity | 3 | 2003 | 1955 | 0.070 |
Why?
|
| Phosphotransferases | 1 | 2008 | 302 | 0.070 |
Why?
|
| Myoblasts | 1 | 2008 | 232 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 1170 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 11075 | 0.070 |
Why?
|
| Heart Failure | 2 | 2010 | 11593 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4567 | 0.070 |
Why?
|
| Ischemia | 1 | 2016 | 1863 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2687 | 0.070 |
Why?
|
| Adenoviridae | 2 | 2003 | 1084 | 0.070 |
Why?
|
| Glutamine | 1 | 2010 | 575 | 0.070 |
Why?
|
| Spodoptera | 1 | 2007 | 141 | 0.070 |
Why?
|
| Myocardium | 2 | 2010 | 4690 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1993 | 778 | 0.070 |
Why?
|
| Anaphase | 1 | 2006 | 116 | 0.070 |
Why?
|
| Arginine | 2 | 2000 | 933 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2009 | 591 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 933 | 0.070 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1997 | 221 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2008 | 570 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2010 | 2673 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2022 | 3416 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 809 | 0.070 |
Why?
|
| Mutation, Missense | 3 | 2019 | 2565 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1997 | 358 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 1459 | 0.070 |
Why?
|
| Protein Subunits | 1 | 2009 | 942 | 0.070 |
Why?
|
| Drosophila Proteins | 1 | 1995 | 1698 | 0.060 |
Why?
|
| Technetium Compounds | 1 | 1985 | 15 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3757 | 0.060 |
Why?
|
| Molecular Probe Techniques | 1 | 2005 | 111 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2006 | 205 | 0.060 |
Why?
|
| Mutant Proteins | 1 | 2007 | 491 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 670 | 0.060 |
Why?
|
| Antimony | 1 | 1985 | 19 | 0.060 |
Why?
|
| Pedigree | 2 | 2011 | 4578 | 0.060 |
Why?
|
| Restriction Mapping | 2 | 1996 | 852 | 0.060 |
Why?
|
| Exons | 5 | 2011 | 2392 | 0.060 |
Why?
|
| Hepatocytes | 2 | 2015 | 1230 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2010 | 1133 | 0.060 |
Why?
|
| Chaperonin Containing TCP-1 | 2 | 2002 | 8 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 277 | 0.060 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 655 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1081 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2003 | 609 | 0.060 |
Why?
|
| Technetium | 1 | 1985 | 321 | 0.060 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2006 | 178 | 0.060 |
Why?
|
| Primary Myelofibrosis | 1 | 1986 | 208 | 0.060 |
Why?
|
| Luminescence | 1 | 2005 | 108 | 0.060 |
Why?
|
| Cinnarizine | 1 | 1984 | 2 | 0.060 |
Why?
|
| Blotting, Far-Western | 1 | 2004 | 3 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2004 | 929 | 0.060 |
Why?
|
| Genome, Human | 3 | 2013 | 4414 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 1759 | 0.060 |
Why?
|
| Endopeptidases | 2 | 2006 | 772 | 0.060 |
Why?
|
| Glucose | 2 | 2020 | 4336 | 0.060 |
Why?
|
| Astrocytes | 1 | 2012 | 1337 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 3 | 2014 | 6209 | 0.060 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2003 | 66 | 0.060 |
Why?
|
| CREB-Binding Protein | 2 | 2000 | 148 | 0.060 |
Why?
|
| Protein Biosynthesis | 4 | 1996 | 2106 | 0.060 |
Why?
|
| Phenylalanine | 1 | 2005 | 365 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 2859 | 0.060 |
Why?
|
| Epidermis | 1 | 2006 | 528 | 0.060 |
Why?
|
| Papillomaviridae | 2 | 2000 | 1121 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 900 | 0.060 |
Why?
|
| Immunotherapy | 2 | 2018 | 4641 | 0.050 |
Why?
|
| Regional Blood Flow | 3 | 1984 | 1485 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 1594 | 0.050 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2003 | 127 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 1332 | 0.050 |
Why?
|
| Cytoplasm | 3 | 1997 | 1514 | 0.050 |
Why?
|
| Estrogens | 1 | 2010 | 1521 | 0.050 |
Why?
|
| Caspases | 1 | 2006 | 876 | 0.050 |
Why?
|
| Salicylanilides | 1 | 2022 | 15 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2018 | 857 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 4342 | 0.050 |
Why?
|
| Medulloblastoma | 1 | 2008 | 678 | 0.050 |
Why?
|
| Cell Compartmentation | 2 | 1995 | 384 | 0.050 |
Why?
|
| Osteosarcoma | 3 | 1999 | 896 | 0.050 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2003 | 89 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2023 | 140 | 0.050 |
Why?
|
| Trophoblasts | 2 | 2001 | 224 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 1991 | 1406 | 0.050 |
Why?
|
| Adenovirus E1B Proteins | 1 | 2001 | 14 | 0.050 |
Why?
|
| Normetanephrine | 1 | 2021 | 25 | 0.050 |
Why?
|
| Drug Stability | 1 | 2002 | 290 | 0.050 |
Why?
|
| Technology, Pharmaceutical | 1 | 2002 | 84 | 0.050 |
Why?
|
| Cell Transplantation | 1 | 2004 | 472 | 0.050 |
Why?
|
| Verapamil | 1 | 1982 | 242 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1992 | 2870 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 189 | 0.050 |
Why?
|
| Sequence Deletion | 3 | 1999 | 1494 | 0.050 |
Why?
|
| Retinoblastoma-Like Protein p107 | 2 | 2000 | 71 | 0.050 |
Why?
|
| Histone Acetyltransferases | 2 | 2000 | 337 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2002 | 343 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1999 | 2470 | 0.050 |
Why?
|
| Kinetics | 3 | 1998 | 6371 | 0.050 |
Why?
|
| Reticulocytes | 1 | 2002 | 288 | 0.050 |
Why?
|
| Helminth Proteins | 1 | 2002 | 172 | 0.050 |
Why?
|
| Fluorescence | 1 | 2004 | 749 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1727 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 828 | 0.050 |
Why?
|
| United States | 3 | 2017 | 71907 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5195 | 0.050 |
Why?
|
| Organ Size | 1 | 2006 | 2248 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 1121 | 0.050 |
Why?
|
| Chromogranins | 1 | 2021 | 161 | 0.050 |
Why?
|
| Breast | 1 | 2010 | 1961 | 0.050 |
Why?
|
| Contrast Sensitivity | 1 | 2002 | 235 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2022 | 411 | 0.050 |
Why?
|
| Cobalt | 1 | 2001 | 154 | 0.050 |
Why?
|
| Albumins | 1 | 2003 | 575 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 1999 | 869 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2006 | 1112 | 0.050 |
Why?
|
| Nocodazole | 1 | 2020 | 95 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 1984 | 694 | 0.040 |
Why?
|
| Hydroxamic Acids | 1 | 2003 | 481 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 2005 | 1199 | 0.040 |
Why?
|
| Micronucleus Tests | 1 | 2019 | 23 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 1999 | 6069 | 0.040 |
Why?
|
| Transcription Factor TFIID | 1 | 2000 | 153 | 0.040 |
Why?
|
| Neurons | 4 | 2008 | 9419 | 0.040 |
Why?
|
| Molecular Weight | 2 | 2001 | 2185 | 0.040 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2000 | 103 | 0.040 |
Why?
|
| MicroRNAs | 2 | 2013 | 3782 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2004 | 965 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 458 | 0.040 |
Why?
|
| Chemokine CXCL9 | 1 | 2019 | 135 | 0.040 |
Why?
|
| Iron | 1 | 2008 | 1785 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2000 | 231 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2010 | 2753 | 0.040 |
Why?
|
| Buthionine Sulfoximine | 1 | 2019 | 17 | 0.040 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2019 | 23 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2002 | 695 | 0.040 |
Why?
|
| Doxycycline | 1 | 2001 | 341 | 0.040 |
Why?
|
| Ubiquitinated Proteins | 1 | 2019 | 32 | 0.040 |
Why?
|
| Thiocyanates | 1 | 2019 | 70 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2008 | 2131 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 664 | 0.040 |
Why?
|
| Glutathione Transferase | 2 | 1991 | 564 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 1704 | 0.040 |
Why?
|
| Protein Interaction Mapping | 1 | 2002 | 617 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3800 | 0.040 |
Why?
|
| Family | 1 | 2009 | 3188 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3774 | 0.040 |
Why?
|
| Benzamides | 1 | 2004 | 1367 | 0.040 |
Why?
|
| Vulvar Neoplasms | 1 | 2000 | 263 | 0.040 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1998 | 100 | 0.040 |
Why?
|
| Lymphedema | 1 | 1985 | 524 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2000 | 1543 | 0.040 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1999 | 266 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2010 | 3665 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2010 | 2455 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2003 | 933 | 0.040 |
Why?
|
| Mammary Glands, Human | 1 | 2019 | 203 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 271 | 0.040 |
Why?
|
| Endolymphatic Sac | 1 | 1997 | 49 | 0.040 |
Why?
|
| Uterus | 2 | 2001 | 649 | 0.040 |
Why?
|
| Fluorescein Angiography | 1 | 2002 | 1044 | 0.040 |
Why?
|
| Ear Neoplasms | 1 | 1997 | 118 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2004 | 2419 | 0.040 |
Why?
|
| Triazoles | 1 | 2022 | 902 | 0.030 |
Why?
|
| RNA Polymerase I | 1 | 1996 | 22 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2016 | 87 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1991 | 3432 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1997 | 222 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2005 | 2695 | 0.030 |
Why?
|
| Cisplatin | 2 | 2019 | 1647 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1996 | 127 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2019 | 600 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 802 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 3602 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 2000 | 1141 | 0.030 |
Why?
|
| Sirolimus | 1 | 2003 | 1532 | 0.030 |
Why?
|
| Kidney Diseases, Cystic | 1 | 1997 | 183 | 0.030 |
Why?
|
| Seeds | 1 | 1996 | 119 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1651 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1997 | 460 | 0.030 |
Why?
|
| Adult | 10 | 2023 | 219747 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 1404 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2002 | 866 | 0.030 |
Why?
|
| Body Weight | 1 | 2006 | 4602 | 0.030 |
Why?
|
| Visual Fields | 1 | 2002 | 1054 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 1997 | 3380 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2000 | 1228 | 0.030 |
Why?
|
| Cytosol | 1 | 1998 | 886 | 0.030 |
Why?
|
| Syndrome | 1 | 2021 | 3261 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 1995 | 262 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1997 | 635 | 0.030 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1994 | 31 | 0.030 |
Why?
|
| Palliative Care | 1 | 2010 | 3568 | 0.030 |
Why?
|
| K562 Cells | 1 | 2016 | 639 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2000 | 4021 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1997 | 499 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1985 | 1402 | 0.030 |
Why?
|
| Lactates | 1 | 2015 | 404 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 416 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2015 | 377 | 0.030 |
Why?
|
| Immune System | 1 | 2019 | 796 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2002 | 1088 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1986 | 2159 | 0.030 |
Why?
|
| RNA | 1 | 2003 | 2716 | 0.030 |
Why?
|
| Pancreatic Cyst | 1 | 1997 | 367 | 0.030 |
Why?
|
| Introns | 1 | 1996 | 978 | 0.030 |
Why?
|
| Gene Library | 1 | 1996 | 1059 | 0.030 |
Why?
|
| Testis | 1 | 1997 | 794 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2015 | 8945 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1999 | 1185 | 0.030 |
Why?
|
| Altitude | 1 | 2014 | 160 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 36271 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 3098 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1997 | 2263 | 0.030 |
Why?
|
| Astrocytoma | 1 | 1997 | 775 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2003 | 6808 | 0.030 |
Why?
|
| Organoids | 1 | 2019 | 729 | 0.030 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1993 | 133 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 1997 | 586 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 727 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 567 | 0.030 |
Why?
|
| U937 Cells | 1 | 2012 | 262 | 0.030 |
Why?
|
| Epithelium | 1 | 1997 | 1605 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1477 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 1996 | 537 | 0.030 |
Why?
|
| Muscles | 1 | 1997 | 1575 | 0.020 |
Why?
|
| Yersinia Infections | 1 | 1991 | 9 | 0.020 |
Why?
|
| Yersinia enterocolitica | 1 | 1991 | 13 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1984 | 2090 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2002 | 2970 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 4710 | 0.020 |
Why?
|
| Cytokines | 1 | 2007 | 7339 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 364 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 13952 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 7982 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 432 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 6841 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2000 | 2532 | 0.020 |
Why?
|
| T-Lymphocytes | 3 | 2000 | 10172 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3156 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 1999 | 1658 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1997 | 1764 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1997 | 1151 | 0.020 |
Why?
|
| Proteomics | 1 | 2004 | 3816 | 0.020 |
Why?
|
| Hydrogen Bonding | 2 | 2002 | 290 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1991 | 534 | 0.020 |
Why?
|
| Streptococcus agalactiae | 1 | 1991 | 337 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1998 | 2905 | 0.020 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2009 | 58 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12950 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2019 | 1994 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 15773 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1996 | 2194 | 0.020 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2008 | 20 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1990 | 649 | 0.020 |
Why?
|
| Streptococcus pyogenes | 1 | 1991 | 293 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 316 | 0.020 |
Why?
|
| Colon | 1 | 1997 | 1788 | 0.020 |
Why?
|
| Prostate | 1 | 1997 | 1761 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2003 | 6549 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2010 | 8145 | 0.020 |
Why?
|
| Child | 3 | 2010 | 79787 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1996 | 1957 | 0.020 |
Why?
|
| Lysine | 1 | 2012 | 998 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 473 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 582 | 0.020 |
Why?
|
| Protein Structure, Secondary | 2 | 2002 | 1229 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 64242 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1991 | 788 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2004 | 1968 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4352 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 2 | 2009 | 3595 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2008 | 331 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 1991 | 616 | 0.020 |
Why?
|
| Endothelium | 1 | 2009 | 764 | 0.020 |
Why?
|
| Protein Folding | 2 | 2002 | 867 | 0.020 |
Why?
|
| Middle Aged | 6 | 2014 | 219219 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2011 | 1125 | 0.020 |
Why?
|
| beta Catenin | 1 | 2011 | 1043 | 0.020 |
Why?
|
| Mesoderm | 1 | 2009 | 672 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4550 | 0.020 |
Why?
|
| Crystallography, X-Ray | 2 | 2002 | 1975 | 0.020 |
Why?
|
| Epigenomics | 1 | 2011 | 936 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 1387 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 1262 | 0.020 |
Why?
|
| Gallium | 1 | 1985 | 27 | 0.020 |
Why?
|
| Cricetinae | 2 | 2001 | 2426 | 0.020 |
Why?
|
| Colloids | 1 | 1985 | 122 | 0.020 |
Why?
|
| Adolescent | 3 | 2021 | 87832 | 0.020 |
Why?
|
| Brain | 3 | 2015 | 26950 | 0.010 |
Why?
|
| Flunarizine | 1 | 1984 | 7 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 294 | 0.010 |
Why?
|
| Risk Factors | 2 | 2007 | 73716 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2005 | 225 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1985 | 495 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 3839 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11065 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein, Saccharomyces cerevisiae | 1 | 2002 | 9 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1991 | 1460 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1996 | 3824 | 0.010 |
Why?
|
| Vascular Resistance | 2 | 1983 | 930 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1995 | 2525 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 2005 | 518 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2009 | 3612 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4047 | 0.010 |
Why?
|
| Microwaves | 1 | 1983 | 185 | 0.010 |
Why?
|
| Cadherins | 1 | 2006 | 898 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1664 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2010 | 42044 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2717 | 0.010 |
Why?
|
| Arm | 1 | 1985 | 583 | 0.010 |
Why?
|
| Genome, Fungal | 1 | 2002 | 203 | 0.010 |
Why?
|
| Young Adult | 3 | 2014 | 58764 | 0.010 |
Why?
|
| Sepsis | 1 | 2015 | 2583 | 0.010 |
Why?
|
| E2F2 Transcription Factor | 1 | 2000 | 35 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2015 | 6349 | 0.010 |
Why?
|
| TATA Box | 1 | 2000 | 127 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11083 | 0.010 |
Why?
|
| Heart | 1 | 2014 | 4382 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2002 | 398 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 1976 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 2000 | 111 | 0.010 |
Why?
|
| Databases, Protein | 1 | 2002 | 387 | 0.010 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2000 | 122 | 0.010 |
Why?
|
| Forecasting | 1 | 2009 | 2919 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1982 | 837 | 0.010 |
Why?
|
| Hyperthermia, Induced | 1 | 1983 | 416 | 0.010 |
Why?
|
| Cystadenoma, Papillary | 1 | 1999 | 9 | 0.010 |
Why?
|
| Hydroxyquinolines | 1 | 1999 | 17 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 1999 | 53 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 1999 | 72 | 0.010 |
Why?
|
| Base Pair Mismatch | 1 | 1999 | 92 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 1999 | 151 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2000 | 735 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 1389 | 0.010 |
Why?
|
| Ankyrins | 1 | 1998 | 123 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1986 | 1173 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2000 | 659 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1998 | 365 | 0.010 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 1998 | 173 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1999 | 564 | 0.010 |
Why?
|
| Prognosis | 2 | 2009 | 29493 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12685 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 574 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 3069 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1986 | 2910 | 0.010 |
Why?
|
| Surface Properties | 1 | 1999 | 1159 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1984 | 2915 | 0.010 |
Why?
|
| Genes, ras | 1 | 1998 | 654 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 2378 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 1998 | 537 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1996 | 255 | 0.010 |
Why?
|
| Feedback | 1 | 1999 | 791 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 1074 | 0.010 |
Why?
|
| Chimera | 1 | 1996 | 452 | 0.010 |
Why?
|
| Temperature | 1 | 2001 | 2219 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41198 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1999 | 911 | 0.010 |
Why?
|
| Genome | 1 | 2002 | 1739 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 1130 | 0.010 |
Why?
|
| Gene Expression | 2 | 1999 | 7584 | 0.010 |
Why?
|
| Hemangioma | 1 | 1999 | 727 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1999 | 934 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1994 | 814 | 0.010 |
Why?
|
| ras Proteins | 1 | 1998 | 1050 | 0.010 |
Why?
|
| Aged | 2 | 2014 | 167889 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1985 | 3474 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1993 | 148 | 0.010 |
Why?
|
| Serum Response Factor | 1 | 1993 | 78 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39018 | 0.010 |
Why?
|
| Proteome | 1 | 2002 | 1855 | 0.010 |
Why?
|
| Gentamicins | 1 | 1993 | 251 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 4113 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 1835 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 1952 | 238 | 0.010 |
Why?
|
| Eye Neoplasms | 1 | 1993 | 306 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1996 | 1243 | 0.010 |
Why?
|
| Heart Rate | 1 | 1982 | 4166 | 0.010 |
Why?
|
| DNA Repair | 1 | 1999 | 2038 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12604 | 0.010 |
Why?
|
| Radiosurgery | 1 | 1999 | 1341 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1996 | 1788 | 0.010 |
Why?
|
| Capillaries | 1 | 1952 | 744 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 8551 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1991 | 20499 | 0.000 |
Why?
|
| Early Diagnosis | 1 | 1952 | 1177 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1991 | 12076 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1982 | 8452 | 0.000 |
Why?
|
| Genetic Testing | 1 | 1999 | 3529 | 0.000 |
Why?
|
| Cardiovascular System | 1 | 1952 | 835 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 2293 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1993 | 5490 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1999 | 5348 | 0.000 |
Why?
|
| Age Factors | 1 | 1996 | 18328 | 0.000 |
Why?
|
| Pregnancy | 1 | 2001 | 29720 | 0.000 |
Why?
|
| Time Factors | 1 | 2000 | 39815 | 0.000 |
Why?
|
| Early Detection of Cancer | 1 | 1952 | 3167 | 0.000 |
Why?
|